New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 29, 2013
10:02 EDTDLR, EQIX, FTNT, ILMN, INXN, MGM, NCR, BMCOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Digital Realty (DLR) downgraded to Neutral from Buy at BofA/Merrill... Equinix (EQIX) downgraded to Neutral from Buy at Citigroup... Fortinet (FTNT) downgraded to Hold from Buy at Wunderlich... Illumina (ILMN) downgraded to Equal Weight from Overweight at First Analysis... InterXion (INXN) downgraded to Neutral from Buy at Citigroup... MGM Resorts (MGM) downgraded to Hold from Buy at Deutsche Bank... NCR Corp. (NCR) downgraded to Neutral from Buy at Compass Point... NYSE Euronext (NYX) downgraded to Underweight from Neutral at HSBC... Netgear (NTGR) downgraded to Sector Perform from Outperform at RBC Capital... PNC Financial (PNC) downgraded to Market Perform from Outperform at Wells Fargo... Ruby Tuesday (RT) downgraded to Neutral from Outperform at Credit Suisse... Seagate (STX) downgraded to Equal Weight from Overweight at Evercore... Unilever (UN) downgraded to Hold from Buy at Jefferies... VMware (VMW) downgraded to Buy from Conviction Buy at Goldman... Pandora (P) downgraded to Neutral from Outperform at Wedbush... BMC Software (BMC) downgraded to Neutral from Outperform at Cowen... NYSE Euronext (NYX) downgraded to Underweight from Neutral at HSBC... Stanley Black & Decker (SWK) downgraded to In-Line from Outperform at Imperial Capital... Sanofi (SNY) downgraded to Equal Weight from Overweight at Barclays.
News For DLR;EQIX;FTNT;ILMN;INXN;MGM;NCR;BMC From The Last 14 Days
Check below for free stories on DLR;EQIX;FTNT;ILMN;INXN;MGM;NCR;BMC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2014
13:27 EDTFTNTAT&T to hold a conference
16th Annual AT&T Cyber Security Conference will be held in New York on September 3-4 with webcast availability on September 4 at 9 am; Webcast Link
August 29, 2014
08:00 EDTFTNTCyber security outlook remains positive, says Wells Fargo
After conducting checks, Wells Fargo believes that demand for cyber security products remains strong, as increased spending trends seen in 1H14 are sustainable through 2H14 and into 2015. The firm thinks that Palo Alto (PANW) stands to benefit most from an upcoming improved network refresh cycle, while Fortinet (FTNT) seems to be gaining traction with enterprises. Wells keeps Outperform ratings on Fortinet PAl Alto and Fireeye (FEYE) and a Market Perform rating on Symantec (SYMC).
August 28, 2014
09:32 EDTMGMNevada reports July statewide gaming win up 0.65% to $931.8M
Subscribe for More Information
06:54 EDTFTNTFortinet coverage resumed with a Hold at Stifel
Subscribe for More Information
August 26, 2014
09:06 EDTNCRNCR announces partnership with Beanstalk Data
Subscribe for More Information
09:04 EDTFTNTFortinet plans to establish R&D center in Singapore
Subscribe for More Information
07:26 EDTMGMMacau estimates lowered at Morgan Stanle
Morgan Stanley lowered Macau 2014 growth estimates to 6% from 12% and 2015 to 11% from 12.5% due to expectations for VIP trends to continue to deteriorate given the China macro impact and notes slowing mass growth rates.
August 21, 2014
05:42 EDTILMNIllumina announces strategic partnership with AstraZeneca, Sanofi, Janssen
Illumina (ILMN) announced it has formed collaborative partnerships with leading pharmaceutical companies to develop a universal next-generation sequencing, or NGS,-based oncology test system. The system will be used for clinical trials of targeted cancer therapies with a goal of developing and commercializing a multi-gene panel for therapeutic selection, resulting in a more comprehensive tool for precision medicine. Initial strategic partners include AstraZeneca (AZN), Janssen Biotech, a Johnson & Johnson (JNJ) company, and Sanofi (SNY). Illumina is working with the strategic partners to develop assays that detect and measure multiple variants simultaneously to support partners’ clinical trials, with the objectives of securing regulatory agency approvals and test commercialization. In parallel, Illumina is working with key thought leaders to set standards for NGS-based assays in routine clinical oncology practice, as well as to define regulatory frameworks to enable this new testing paradigm. Together, Illumina and its strategic partners aim to transition from single-analyte companion diagnostics to panel-based assays that select for “companion therapeutics.”
August 20, 2014
10:04 EDTILMNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:18 EDTILMNIllumina upgraded to Outperform from Neutral at Wedbush
Subscribe for More Information
August 19, 2014
15:49 EDTEQIXStephens to hold a field trip
Subscribe for More Information
11:32 EDTILMNLabCorp prenatal test a negative for Sequenom, says Maxim
Maxim views LabCorp's (LH) announcement today that it will begin offering the informaSeq prenatal test as a long-term negative for Sequenom (SQNM) due to increased competition. The news is also negative for Illumina (ILMN) and PerkinElmer (PKI), who both offer Non-Invasive Prenatal Tests, Maxim adds. The firm recommends buying shares of LabCorp and keeps a Buy rating on the name with a $130 price target.
08:06 EDTNCRNCR Corp. selected by GECU for digital and physical banking
GECU is bringing convenient, intuitive, and easy-to-use services across both its digital and physical channels through the innovative technology of NCR Corporation. GECU provides its members with online and mobile digital banking services from Digital Insight, an NCR company, while also installing NCR Interactive Teller in new neighborhood branches. GECU has agreed to renew Digital Insight’s suite of SaaS solutions including Online Banking, iOS and Android mobile and tablet banking, Remote Deposit Capture, FinanceWorks and Purchase Rewards.
August 18, 2014
08:47 EDTINXN, EQIXRaymond James to hold a summit
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use